MA41850A - Nouvelles utilisations pharmaceutiques - Google Patents

Nouvelles utilisations pharmaceutiques

Info

Publication number
MA41850A
MA41850A MA041850A MA41850A MA41850A MA 41850 A MA41850 A MA 41850A MA 041850 A MA041850 A MA 041850A MA 41850 A MA41850 A MA 41850A MA 41850 A MA41850 A MA 41850A
Authority
MA
Morocco
Prior art keywords
new pharmaceutical
pharmaceutical uses
new
pharmaceutical
Prior art date
Application number
MA041850A
Other languages
English (en)
Inventor
Mark Hibberd
Richard Jenkins
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55806738&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA41850(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB1505526.2A external-priority patent/GB201505526D0/en
Priority claimed from GBGB1521015.6A external-priority patent/GB201521015D0/en
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of MA41850A publication Critical patent/MA41850A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA041850A 2015-03-31 2016-03-29 Nouvelles utilisations pharmaceutiques MA41850A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1505526.2A GB201505526D0 (en) 2015-03-31 2015-03-31 Novel pharmaceutical uses
GBGB1521015.6A GB201521015D0 (en) 2015-11-27 2015-11-27 Novel pharmaceutical uses

Publications (1)

Publication Number Publication Date
MA41850A true MA41850A (fr) 2018-02-06

Family

ID=55806738

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041850A MA41850A (fr) 2015-03-31 2016-03-29 Nouvelles utilisations pharmaceutiques

Country Status (22)

Country Link
US (2) US20180085361A1 (fr)
EP (1) EP3277279A1 (fr)
JP (1) JP2018513140A (fr)
KR (1) KR20170132260A (fr)
CN (1) CN107530335A (fr)
AU (1) AU2016241069A1 (fr)
BR (1) BR112017021024A2 (fr)
CA (1) CA2981244A1 (fr)
CL (1) CL2017002325A1 (fr)
CO (1) CO2017010019A2 (fr)
CR (1) CR20170404A (fr)
DO (1) DOP2017000218A (fr)
EA (1) EA201792148A1 (fr)
EC (1) ECSP17072984A (fr)
IL (1) IL254419A0 (fr)
MA (1) MA41850A (fr)
MX (1) MX2017012414A (fr)
PE (1) PE20180195A1 (fr)
PH (1) PH12017501751A1 (fr)
SG (1) SG11201706739WA (fr)
TN (1) TN2017000416A1 (fr)
WO (1) WO2016159386A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201639853A (zh) 2015-03-31 2016-11-16 木塔比利斯公司 雜環化合物及其於預防或治療細菌感染之用途
TWI838340B (zh) 2017-07-10 2024-04-11 日商武田藥品工業股份有限公司 含有沃諾拉贊的製劑
CN114642642A (zh) * 2020-12-18 2022-06-21 上海天慈生物谷生物工程有限公司 5-(2-氟苯基)-n-甲基-1-(3-吡啶基磺酰基)-1h-吡咯-3-甲胺制剂
KR102851644B1 (ko) * 2021-07-28 2025-08-28 대봉엘에스 주식회사 보노프라잔 공형성화물, 및 이의 제조방법
KR20250036905A (ko) * 2022-08-04 2025-03-14 쟝쑤 케어파르 파마슈티컬 컴퍼니 리미티드 피롤류 위산분비 억제제를 함유하는 약물 조성물 및 그 제조 방법
CN116270443A (zh) * 2022-10-27 2023-06-23 广州白云山天心制药股份有限公司 富马酸伏诺拉生注射液及其制备方法
CN115944743B (zh) * 2023-01-18 2025-08-08 山东诚成医药科技有限公司 一种富马酸伏诺拉生组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100958829B1 (ko) 2004-09-03 2010-05-25 주식회사유한양행 피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법
US20080255200A1 (en) * 2007-04-11 2008-10-16 Auspex Pharmaceuticals, Inc. Substituted benzimidazoles
TW201431552A (zh) 2008-07-28 2014-08-16 Takeda Pharmaceutical 醫藥組成物
KR101605063B1 (ko) 2009-07-09 2016-03-21 라퀄리아 파마 인코포레이티드 소화관 운동이상이 관여하는 질환의 치료용 산 펌프 길항제
US20120070468A1 (en) * 2010-09-16 2012-03-22 Uop Llc Removal of toxins from gastrointestinal fluids
WO2014133059A1 (fr) 2013-02-28 2014-09-04 武田薬品工業株式会社 Procédé de production d'un composé de chlorure de sulfonyle
CN103951652B (zh) * 2014-04-18 2015-09-23 潍坊博创国际生物医药研究院 5-(2-氟苯基)-n-甲基-1-(3-吡啶基磺酰基)-1h-吡咯-3-甲胺水溶性有机酸盐和注射剂及它们的制备方法

Also Published As

Publication number Publication date
US20190070159A1 (en) 2019-03-07
ECSP17072984A (es) 2018-02-28
CN107530335A (zh) 2018-01-02
DOP2017000218A (es) 2018-01-31
PH12017501751A1 (en) 2018-04-11
CL2017002325A1 (es) 2017-12-29
IL254419A0 (en) 2017-11-30
TN2017000416A1 (en) 2019-01-16
PE20180195A1 (es) 2018-01-26
BR112017021024A2 (pt) 2018-07-03
EA201792148A1 (ru) 2018-02-28
US20180085361A1 (en) 2018-03-29
KR20170132260A (ko) 2017-12-01
WO2016159386A1 (fr) 2016-10-06
SG11201706739WA (en) 2017-09-28
EP3277279A1 (fr) 2018-02-07
JP2018513140A (ja) 2018-05-24
CR20170404A (es) 2018-01-10
CA2981244A1 (fr) 2016-10-06
CO2017010019A2 (es) 2018-02-20
AU2016241069A1 (en) 2017-09-21
MX2017012414A (es) 2018-01-26

Similar Documents

Publication Publication Date Title
IL258931A (en) Therapeutic compounds and methods
EP3509589A4 (fr) Nouvelles utilisations
EP3334706A4 (fr) Pillararènes et utilisations de ceux-ci
EP3344624A4 (fr) Inhibiteurs de tyk2 et leurs utilisations
MA50541A (fr) Formulations pharmaceutiques
DK3297605T3 (da) Topiske, farmaceutiske sammesætninger
EP3689892A4 (fr) Médicament radioactif
BR112017027227A2 (pt) Agente anti-câncer
EP3500255A4 (fr) Compositions pharmaceutiques ophtalmiques et utilisations associées
EP3538261A4 (fr) Catalyseurs en pérovskite et leurs utilisations
MA42303A (fr) Formulations pharmaceutiques
DK4197530T3 (da) Ribociclib-tablet
EP3341007A4 (fr) Inhibiteurs de malt1 et leurs utilisations
EP3316685A4 (fr) Compositions pharmaceutiques lyophilisées
EP3347021A4 (fr) Cyano-thiénotriazoloazépines et leurs utilisations
EP3463345A4 (fr) Combinaisons pharmaceutiques
MA41850A (fr) Nouvelles utilisations pharmaceutiques
EP3437644A4 (fr) Médicament
IL259234B (en) Cephem compounds, their production and use
KR20180084810A (ko) 정제 세트
HUE048503T2 (hu) Dihidropirimidin-2-on vegyületek és gyógyszerészeti alkalmazásai
EP3527216A4 (fr) Médicament
EP3383401A4 (fr) Dérivés de thiéno-pyrimidine et utilisations de ceux-ci
MA49837A (fr) Compositions pharmaceutiques
EP3246304A4 (fr) Dérivé diphényle et utilisations associées